SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001250853-12-000053
Filing Date
2012-05-25
Accepted
2012-05-25 16:36:45
Documents
1
Period of Report
2012-05-25

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 9917
  Complete submission text file 0001250853-12-000053.txt   11610
Mailing Address 21900 BURBANK BLVD. 3RD FLOOR WOODLAND HILLS CA 91367
Business Address 21900 BURBANK BLVD. 3RD FLOOR WOODLAND HILLS CA 91367 818-992-2907
ImmunoCellular Therapeutics, Ltd. (Issuer) CIK: 0000822411 (see all company filings)

IRS No.: 931301885 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 21900 BURBANK BOULEVARD, 3RD FLOOR WOODLAND HILLS CA 91367
Business Address
Singh Manish (Reporting) CIK: 0001550588 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35560 | Film No.: 12871805